19-16889846-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003950.4(F2RL3):c.383C>T(p.Ala128Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000351 in 1,596,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003950.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F2RL3 | NM_003950.4 | c.383C>T | p.Ala128Val | missense_variant | 2/2 | ENST00000248076.4 | NP_003941.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F2RL3 | ENST00000248076.4 | c.383C>T | p.Ala128Val | missense_variant | 2/2 | 1 | NM_003950.4 | ENSP00000248076.2 | ||
F2RL3 | ENST00000599210.1 | c.*37C>T | 3_prime_UTR_variant | 2/2 | 2 | ENSP00000471518.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152084Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000788 AC: 17AN: 215868Hom.: 0 AF XY: 0.0000750 AC XY: 9AN XY: 119970
GnomAD4 exome AF: 0.0000339 AC: 49AN: 1444024Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 29AN XY: 718600
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.383C>T (p.A128V) alteration is located in exon 2 (coding exon 2) of the F2RL3 gene. This alteration results from a C to T substitution at nucleotide position 383, causing the alanine (A) at amino acid position 128 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at